This article presents results of a cross-sectional county-level study using all reported direct-to-physician pharmaceutical payments from manufacturers of opioid use disorder medications from 2014-2017, as well as demographic and economic data from 3,140 counties. It features statistics with breakdowns by metropolitan, micropolitan, and rural areas. Read more here.
